DS Läkarkonsult AB

Active
559359-3774Limited company (AB)Registered 2022VÄXJÖ

Key figures

2 038 535 kr+55,3%
Revenue 2025
+23,2%
Average annual growth 2023–2025
01 m2 m3 m202320242025

Key figures

2025

Summary: DS Läkarkonsult AB

What kind of company is it?

DS Läkarkonsult AB (org. no. 559359-3774) is a limited company (AB). The company was registered in 2022 and has existed for 4 years. Registered seat: Växjö. Industry according to Statistics Sweden: specialist medical practice activities, not at hospitals (SNI 86222).

How is the company doing financially?

Net sales in financial year 2025 were 2 038 535 kr, up 55,3 % on the previous year (1 312 323 kr). From 2023 to 2025, net sales grew by an average of 23,2 % per year. Net profit for 2025 was 535 183 kr (26,3 % of net sales). The company was profitable in all 3 reported financial years. At the end of financial year 2025, total assets were 954 762 kr and equity 721 254 kr (equity ratio 75,5 %). The annual report for 2025 proposes a dividend of 322 400 kr.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2025

Proposed dividend 322 400 kr.

History
2025322 400 kr
2024300 000 kr
Summary of annual reports2023–2025
202320242025
Sales revenue1 342 9991 312 3232 038 535
Profit for the reporting year170 250203 883535 183
Retained earnings of previous periods———
Total assets1 031 491707 798954 762
Total liabilities399 302221 726233 508
Total equity632 189486 072721 254
Employees———
Proposed dividend—300 000322 400

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.